Fernando Bril

8.2k citations
85 papers · 5.8k · 6 hit papers · h-index 35

Impact in

  • Epidemiology top 0.2%
    • Liver Disease Diagnosis and Treatment
  • Hepatology top 0.5%
    • Liver Disease and Transplantation

Papers in

Fernando Bril

83 papers receiving 5.7k citations

Fernando Bril's Hit Papers

Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLD 2025 · 41 citations
410+3+7Years since publication250500750

Peers

Fernando Bril
Comparison fields: 5 of 104
  • Epidemiology 4.4k
  • Hepatology 960
  • Endocrinology, Diabetes and Metabolism 2.0k
  • Pathology and Forensic Medicine 507
  • Physiology 619
Replace Stefano Ballestri with:
Stefano Ballestri Italy
James M. Paik United States
Pegah Golabi United States
Romina Lomonaco United States
Dinan Abdelatif United States
Shivakumar Chitturi Australia
Aynur Ünalp United States
Fabio Nascimbeni Italy
Yousef Fazel United States
Ester Vanni Italy
Fernando Bril relative to Stefano Ballestri Italy Stefano Ballestri's profile →
Citations per field
00.5×1.5×2.0×
Stefano Ballestri · 1×
Citations per year

Countries citing papers authored by Fernando Bril

Since Specialization
Citations

This map shows the geographic impact of Fernando Bril's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando Bril with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando Bril more than expected).

Fields of papers citing papers by Fernando Bril

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernando Bril. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando Bril. The network helps show where Fernando Bril may publish in the future.

Co-authors

The 25 scholars most cited alongside Fernando Bril, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fernando Bril Line = papers co-authored together Fernando Bril links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
Hit paper breakdown →
2016753
2
Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease
Hit paper breakdown →
2018417
3
High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels
Hit paper breakdown →
2015396
4 2017260
5 2016252
6
Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial
Hit paper breakdown →
2019245
7
Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening
Hit paper breakdown →
2020240
8 2016217
9 2013193
10 2015182
11 2017161
12 2014155
13 2018140
14 2015138
15 2013137
16 2019133
17 2013128
18 2016118
19 2016111
20 201494

About Fernando Bril

Fernando Bril is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism, Molecular Biology, Pathology and Forensic Medicine and Reproductive Medicine, having authored 85 papers that have together received 5.8k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (59 papers), Diet, Metabolism, and Disease (18 papers), Ovarian function and disorders (6 papers), Alcohol Consumption and Health Effects (5 papers), Liver Diseases and Immunity (4 papers), Diabetes Treatment and Management (3 papers), Metabolomics and Mass Spectrometry Studies (3 papers) and Hepatitis C virus research (3 papers). The work is most often cited by research in Epidemiology (4.4k citations), Hepatology (960 citations), Endocrinology, Diabetes and Metabolism (2.0k citations), Pathology and Forensic Medicine (507 citations) and Physiology (619 citations). Fernando Bril has collaborated with scholars based in United States, France and Argentina. Frequent co-authors include Kenneth Cusi, Romina Lomonaco, Beverly Orsak, Fermin O. Tio, Joan Hecht, Paola Portillo-Sánchez, Nishanth E. Sunny, Amy Webb, Srilaxmi Kalavalapalli and Diane Biernacki. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care, Diabetes, Hepatology and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact